Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02188160Phase 2Completed
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Dry Eye SyndromesKeratoconjunctivitis Sicca
Principalinvestigator

Research Network

Collaboration Network

16 collaborators·54 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Whitsett Vision Group

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Daniel Brocks, MD

Boston Sight

Moderately Similar
4 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca
Similarity Score30%

Gail Torkildsen, MD

Andover Eye Associates

Moderately Similar
14 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca
Similarity Score30%

Michelle Senchyna

Allergan

Moderately Similar
4 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca
Similarity Score30%

Jodi Luchs, MD

South Shore Eye Center

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Gregg Berdy, MD

Ophthalmology Associates

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Steven Rauchman, MD

North Valley Eye Medical Group

Related
2 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Mark Milner, MD

Eye Center of Southern CT, P.C.

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

David Evans, OD

Total Eye Care, PA

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Joseph Martel, MD

Martel Eye Medical Group

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Michael Korenfeld, MD

Ecomprehensive Eye Care, Ltd / Vision Research Institute LLC

Related
1 trials

Shared therapeutic areas:

Dry Eye SyndromesKeratoconjunctivitis Sicca

Worked with same sponsors:

Kala Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02188160Phase 2PrincipalInvestigator

Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease

Dry Eye SyndromesKeratoconjunctivitis Sicca
Completed

All 1 trials loaded